Intrathyroidal fetal microchimerism in Graves' disease.

J Clin Endocrinol Metab

Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029, USA.

Published: July 2002

AI Article Synopsis

  • Fetal cells from male offspring can enter the mother's bloodstream and tissues during pregnancy, a phenomenon known as fetal microchimerism.
  • The study explored the connection between these fetal cells and changes in autoimmune thyroid disease, specifically Graves' disease, which often stabilizes during pregnancy and worsens after childbirth.
  • Through advanced DNA detection techniques, the researchers found evidence of male fetal cells in thyroid tissue samples from women with Graves' disease, suggesting these cells may play a role in influencing the immune response related to this condition.

Article Abstract

During pregnancy, fetal cells are known to reach the maternal circulation and infiltrate a variety of tissues (fetal microchimerism). Although the presence of such cells has the potential to modulate the maternal immune response to both self antigens and fetal alloantigens, the degree of their influence remains unclear. The hyperthyroidism of Graves' disease frequently abates during pregnancy and exacerbates after childbearing. Thus, we have hypothesized that fetal cells in the maternal circulation and tissues may influence this decrescendo to crescendo pattern of autoimmune thyroid disease. Part of this hypothesis was tested using an ELISA-PCR for the detection of DNA for a male-specific gene, sex-determining region Y. The sensitivity of this assay was the equivalent of approximately 1 male cell among 10(5) female cells. We initially examined paraffin-embedded thyroid tissues and detected male cells in 4 of 20 female Graves' thyroid specimens, but not in 6 of 6 female adenoma specimens. Using frozen thyroid tissue specimens, an additional 6 of 7 Graves' disease samples demonstrated intrathyroidal fetal microchimerism, whereas 1 of 4 female samples with thyroid nodules showed male cells. The greater detection of the sex-determining region Y gene in frozen female thyroid tissues was probably due to DNA fragmentation in the paraffin-derived samples. In summary, we demonstrated that intrathyroidal fetal microchimerism was common and profound in female patients with Graves' disease. Thus, fetal male cells are valid candidates for modulating autoimmune thyroid disease in pregnancy and postpartum.

Download full-text PDF

Source
http://dx.doi.org/10.1210/jcem.87.7.8656DOI Listing

Publication Analysis

Top Keywords

fetal microchimerism
16
graves' disease
16
intrathyroidal fetal
12
male cells
12
disease pregnancy
8
fetal cells
8
maternal circulation
8
autoimmune thyroid
8
thyroid disease
8
sex-determining region
8

Similar Publications

Microchimerism is defined as the presence of a small population of genetically distinct cells within a host that is derived from another individual. Throughout pregnancy, maternal and fetal cells are known to traffic across the feto-maternal interface and result in maternal and fetal microchimerism, respectively. However, the routes of cell transfer, the molecular signaling as well as the timing in which trafficking takes place are still not completely understood.

View Article and Find Full Text PDF

Microchimerism: The mystery of multiple DNA and its implications in forensic sciences.

Forensic Sci Int

December 2024

Department of Science, Institute of Forensic Sciences and Legal Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey. Electronic address:

Microchimerism (MC) refers to the presence of small amounts of foreign cells or DNA in the tissues or circulation of an individual. It generally occurs through mother-fetus interaction, twin pregnancies, and intergenerational transmission. MC is influenced by genetic and environmental factors such as toxic conditions, immunological suppression, and various diseases (influenza, COVID-19, etc.

View Article and Find Full Text PDF

Transient abnormal myelopoiesis (TAM) generally affects newborns with Down syndrome and is associated with constitutional trisomy 21 and a somatic GATA1 mutation. Here we describe a case of TAM which evolved after umbilical cord blood transplantation (UCBT), whose origin was identified as a GATA1 mutation-harboring clone in umbilical cord blood (UCB) by detailed genetic analyses. A 58-year-old male who received UCBT for peripheral T-cell lymphoma presented progressive anemia and thrombocytopenia, and leukocytosis with blast cells in the peripheral blood (PB).

View Article and Find Full Text PDF

Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation.

Semin Immunopathol

December 2024

Division of Pediatric Stem Cell Transplantation and Immunology, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Toleration of a semi-allogeneic fetus in the mother's uterus as well as tolerance after allogeneic hematopoietic stem cell transplantation (HSCT) appear to share some immunologic concepts. The existence of microchimeric cells, and the original idea of a bidirectional cell trafficking between mother and child during pregnancy have been known for decades. Today, origins and mechanisms of persistence of microchimeric cells are intensively being elucidated.

View Article and Find Full Text PDF
Article Synopsis
  • - In utero hematopoietic cell transplantation (IUHCT) takes advantage of the fetus's immune tolerance to successfully introduce donor cells without prior conditioning or immunosuppression, aiming for long-lasting cell integration.
  • - A study injected adult bone marrow cells into fetal mice at gestational ages 12-17 days, finding the highest concentration of donor cells in the brain when injected between GA 13-14, with significant persistence of these cells in the hindbrain.
  • - This research is groundbreaking as it details how donor cells migrate into the nervous system during fetal development, laying the groundwork for using IUHCT to potentially treat neurogenetic disorders.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!